Volume 30, Number 12—December 2024
Research
Rio Mamore Hantavirus Endemicity, Peruvian Amazon, 2020
Table 2
Sample | IgM ELISA ratio† |
PCR copies/mL |
Non–antigen coated plate OD | ||||||
---|---|---|---|---|---|---|---|---|---|
CCHFV | CHIKV | MAYV | OROV | Plasmodium spp. | EBV | CMV | |||
1395‡ | 1.19 | 1.59 | 1.46 | 0.89 | Negative | Negative | Negative | 0.19 | |
3261 | 5.38 | 5.91 | 5.61 | 5.94 | Negative | Negative | Negative | 0.80 | |
3265 | 1.82 | 1.10 | 0.75 | 1.30 | 8.4 × 105 | 4.4 × 103 | 1.9 × 103 | 0.93 | |
3281 | 1.97 | 2.82 | 3.75 | 6.50 | Negative | Negative | Negative | 0.73 | |
3345 | 2.97 | 7.55 | 6.56 | 2.96 | Negative | Negative | 4.2 × 103 | 0.86 | |
3358 | 7.95 | 10.86 | 10.25 | 9.11 | 2.8 × 104 | Negative | Negative | 0.88 | |
3376 | 0.34 | 0.65 | 0.80 | 0.60 | Negative | Negative | Negative | 0.26 | |
3630 | 3.61 | 3.80 | 2.17 | 1.30 | Negative | Negative | Negative | 0.64 | |
4242‡ | 2.43 | 1.74 | 1.47 | 1.97 | Negative | Negative | Negative | 0.77 | |
4432 | 0.32 | 0.45 | 0.33 | 0.31 | Negative | Negative | Negative | 0.15 | |
4605 | 1.28 | 1.74 | 2.63 | 11.04 | Negative | Negative | Negative | 0.50 | |
4893 | 1.22 | 2.44 | 1.81 | 1.90 | Negative | Negative | Negative | 0.61 |
*Boldface indicates samples that tested positive. CCHFV, Crimean-Congo hemorrhagic fever virus; CHIKV, chikungunya virus; CMV, cytomegalovirus; EBV, Epstein-Barr virus; MAYV, Mayaro virus; OROV, Oropouche virus. The sample that tested positive by reverse transcription PCR was not tested because of limited sample volume after isolation attempts. OD of the negative control for IgM in Sin Nombre virus/Andes virus ELISA on a noncoated plate, 0.15. (Mann-Whitney U test, MAYV, U = 44; OROV, U = 56; CCHFV, U = 20, CHIKV, U = 15, p<0.001 for all). †Boldface indicates results with a ratio >1.1 considered positive in all ELISAs. ‡Samples that tested positive by hantavirus IFA.
Page created: October 25, 2024
Page updated: November 26, 2024
Page reviewed: November 26, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.